Photo

613.801.1072

...

Ottawa

English, Mandarin

Fanqi (Grace) Wang

Associate Lawyer

Grace has been called to the Ontario Bar in May 2021 and is currently an Associate Lawyer at MBM’s Ottawa office.

She graduated with a Bachelor of Engineering degree from the National University of Singapore (“NUS”) in 2011 and later went back to NUS to complete her Master of Science degree in 2016. Grace is a certified Project Management Professional (PMP) with 6 years of work experience in project management and business operations, that she gained before starting law school.

Grace is passionate about innovation and always wanted to be an intellectual property lawyer. In 2017, Grace went to the Osgoode Hall Law School of York University (“Osgoode”) where she completed her Juris Doctor degree. During her time at Osgoode, she volunteered at the IP Osgoode Innovation Clinic, helping provide pro bono IP and technology law information and assistance to start-ups and inventors working to commercialize their inventions and pursue IP protections.

At MBM, Grace is assisting MBM professionals with various intellectual property matters. 

In her free time, Grace is an avid travel enthusiast and enjoys reading comics and cooking.

Education

  • J.D. – Osgoode Hall Law School, York University.
  • Master of Science (Supply Chain Management) - National University of Singapore
  • Bachelor of Engineering (Industrial and Systems Engineering) – National University of Singapore
  • PMP - Project Management Institute

cb photo 91 561829f6d3c22

DR. SUZANNE HOF

Patent Agent


Suzanne focuses on the drafting and prosecuting of biochemical, pharmaceutical, chemical as well as cleantech and green technology patents.MBM read_more_btn

 

MBM logo

About MBM

 The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.Read More About MBM

Clarifications to the Data Protection Guidance Document

Health Canada recently announced that section 2.1 of its Guidance Document re: Data Protection has been amended to clarify that the prior approval of a medicinal ingredient in a drug for veterinary use will not preclude the granting of data protection for a drug for...Read More